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Abstract 31 
Background & aims: Undernutrition is associated with increased hospital costs. Whether 32 
these increased costs are totally compensated by third payer systems has not been assessed. 33 
We aimed to assess the differences between actual and reimbursed hospital costs according to 34 
presence/absence of nutritional risk, defined by a Nutritional risk screening-2002 (NRS-35 
2002) score≥3. 36 
Methods: Retrospective study. Administrative data for years 2013 and 2014 of the 37 
department of internal medicine of the Lausanne university hospital. The data included total 38 
and specific costs (i.e. clinical biology, treatments, pathology). Reimbursed costs were based 39 
on the Swiss Diagnosis Related Group (DRG) system.  40 
Results: 2200 admissions with NRS-2002 data were included (mean age 76 years, 53.9% 41 
women), 1398 (63.6%) of which were considered nutritionally ‘at-risk’. After multivariate 42 
adjustment, patients nutritionally ‘at-risk’ had higher costs (multivariate-adjusted 43 
difference±standard error: 34’206±1246 vs. 22’214±1666 CHF, p<0.001) and higher 44 
reimbursements (26’376±1105 vs. 17’783±1477 CHF, p<0.001). Still, the latter failed to 45 
cover the costs, leading to a deficit between costs and reimbursements of 7831±660 CHF in 46 
patients ‘at-risk’ vs. 4431±881 in patients ‘not at-risk’ (p<0.003). Being nutritionally ‘at-risk’ 47 
also led to a lower likelihood of complete coverage of costs: multivariate-adjusted odds ratio 48 
and 95% confidence interval 0.77 (0.62-0.97). Patients ‘at-risk’ had lower percentage of total 49 
costs in medical interventions, food, imaging and “other”, but the absolute differences were 50 
less than 2%. 51 
Conclusion: Hospital costs of patients nutritionally ‘at-risk’ are less well reimbursed than of 52 
patients ‘not at-risk’. Better reporting of undernutrition in medical records and better 53 
reimbursement of undernourished patients is needed. 54 
Keywords: Diagnosis-related groups; costs; reimbursements; hospital undernutrition. 55 
56 
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Introduction 57 
Undernutrition is a common feature among hospitalized patients: in Switzerland, it is 58 
present in slightly less than one out of five patients [1, 2]. Undernutrition leads to increased 59 
in-hospital morbidity and mortality [3], as well as increased hospital costs [4, 5]. In most 60 
European countries, health costs are covered by the government, prepaid private insurances 61 
and the patients themselves [6]. Switzerland has one of the best health systems in the word 62 
[7], which also ranks amongst the most expensive: total health costs for 2013 were estimated 63 
at 9752 US$ per capita, almost one quarter (22.9%) being paid by the patients [6]. In 64 
Switzerland, hospitals are reimbursed based on the Diagnosis Related Groups (DRG), a 65 
system aimed at making hospital paying more transparent and also at evaluating hospital 66 
performance [8]. The Swiss Diagnosis Related Groups (Swiss DRG) system exists since 67 
2012, is based on its German counterpart and has approximately 1000 different categories 68 
[9]. In a well-managed system, hospital costs should be balanced by reimbursements; hence, 69 
the highest hospital costs due to undernutrition should be covered by higher reimbursements, 70 
provided the adequate DRG codes are indicated. Still, whether this is actually the case has 71 
never been assessed. 72 
We have previously shown that being nutritionally ‘at-risk’ was associated with 73 
higher in-hospital mortality and total costs [10]. We now assessed the costs, reimbursements 74 
and corresponding net result (i.e. the difference between costs and reimbursements) 75 
according to presence/absence of nutritional risk. We also assessed the distribution of specific 76 
costs (i.e. related to imaging, laboratory analyses, etc.) according to presence/absence of 77 
nutritional risk. The objective is to know whether patients nutritionally ‘at-risk’ differ from 78 
the others regarding specific costs and if they represent a financial burden for the institution. 79 
4 
 
Materials and methods 80 
Study design 81 
This is a retrospective study using electronic administrative data for years 2013 and 82 
2014 of the department of internal medicine of the Lausanne university hospital. Data from 83 
all adult (≥18 years old) hospitalizations who stayed at least one day (≥24 hours) in the 84 
department of internal medicine was collected and coded before being handled for analysis. 85 
Data extraction, merging and coding was performed by a specific team of the Lausanne 86 
university hospital and the investigators were blinded to the hospitalizations’ identities. 87 
Nutritional risk screening and data collection procedure  88 
Nutritional risk screening was defined by the presence of NRS-2002 score in the 89 
electronic medical records. Since January 2013, all data related to nutritional status (including 90 
screening) is available in the patient’s electronic file. According to the Lausanne university 91 
hospital guideline, undernutrition risk screening should, whenever possible, include all 92 
patients, and be systematic for patients with chronic obstructive pulmonary disease (COPD) 93 
and heart failure. For the other patients, decision for screening is based on the subjective 94 
evaluation by the health care team. Evaluation should be based on the NRS-2002 of the 95 
Danish Society for Parenteral and Enteral Nutrition [11, 12]. The reason for focusing on 96 
patients with COPD and heart failure is the high prevalence of undernutrition among those 97 
patients [13, 14]. 98 
Hospitalized patients were interviewed the first day of admission about their 99 
nutritional status, and nutritional risk scoring was performed according to the NRS-2002 100 
criteria. Nutritional risk was scored from 0 to 3; disease severity was scored from 0 to 3, and 101 
an extra score of 1 was added to hospitalizations older than 70 years. The nutritional risk 102 
score is determined due to three different parameters 1) quartile decreased of estimated oral 103 
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food intake requirements, 2) presence of weight loss more than 5% within the previous 1 to 3 104 
months and 3) low body mass index. The severity of disease was categorized as none, slight, 105 
moderate and severe with the score of 0 to 3, respectively. The scores were added and 106 
hospitalizations with a NRS-2002 score ≥3 were considered as nutritionally ‘at-risk’. 107 
Costs and reimbursements 108 
Actual total and specific costs (i.e. related to treatments, medical interventions, 109 
imaging, laboratory analyses, food, intensive care units…) were collected from the hospital 110 
accounting system. Costs were expressed in Swiss Francs (CHF); 1 CHF=1.021 US$ or 0.919 111 
€ (www.xe.com, assessed 29th of June, 2016). Specific costs were expressed as percentage of 112 
the total costs. Only specific costs whose median represented at least 1% of total costs were 113 
considered; hence, costs related to anesthesia (median=0); pathology (median=0); 114 
dialysis/transplantation (median=0) and medications (median=0.6) were not considered. Of 115 
note, the costs related to food include neither oral nutritional supplements (ONS), nor enteral 116 
or parenteral nutrition, and costs related to ONS could not be identified from the files. 117 
Reimbursements were computed according to the Swiss DRG [9]. We considered 1 118 
DRG point=10’500 CHF (average value for 2014). For each patient, the difference between 119 
costs and reimbursements was also computed. Total costs and reimbursements were used 120 
either as continuous variables or categorized into lower/higher than the 75th percentile or 121 
lower/higher than the 90th percentile. Coverage of the costs was computed as the ratio of 122 
costs/reimbursements and expressed as percentage, or categorized as complete (≥100%) or 123 
less than complete (<100%). 124 
Other variables 125 
Socio-demographic data included age, sex and origin (i.e. coming from home or other 126 
health care facilities). Medical data included International classification of diseases, version 127 
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10 (ICD-10) codes for the main cause of hospitalization and comorbidities (up to 26), and 128 
vital status at discharge (alive or dead). Main cause of hospitalization was categorized into 129 
infectious, oncologic, endocrine, neuro-psychiatric, cardiologic, pulmonary, digestive, bone 130 
and joint, urologic, and other. The Charlson Index was computed from ICD-10 codes 131 
according to an algorithm defined for Switzerland [15]. Total hospital length of stay (in 132 
internal medicine and other departments) was collected. Data for the medical provision 133 
categories (groupe de prestations or GPC), a system assessing the main type of medical 134 
treatment (i.e. intensive care, respiratory system, pain management, infection…) was also 135 
collected. 136 
Exclusion criteria 137 
Hospitalizations were excluded if there was a lack of information on NRS-2002, 138 
costs, sex, age, origin, main diagnosis, or Charlson Index; moreover, patients with main 139 
diagnosis of obstetric and/or gynecological disease were also excluded as they usually 140 
managed in other departments of the hospital.  141 
Statistical analysis 142 
Statistical analyses were performed using Stata version 14.1 for windows (Stata Corp, 143 
College Station, Texas, USA). Descriptive results were expressed as number of participants 144 
(percentage) or as average ± standard deviation. Bivariate analyses were performed using chi-145 
square for categorical variables and Student’s t-test or Kruskal-Wallis test for continuous 146 
variables. Associations between variables were assessed using Spearman rank correlation. 147 
For continuous variables, multivariate analysis was performed using analysis of variance and 148 
results were expressed as multivariate-adjusted mean ± standard error. Due to the skewness 149 
of the distribution of costs leading to large confidence intervals of the estimates, an analysis 150 
based on quantiles of costs was performed to confirm the findings. For dichotomous 151 
variables, multivariate analysis was performed using logistic regression and the results were 152 
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expressed as odds ratio (OR) and 95% confidence interval (CI). Sensitivity analyses were 153 
carried out after excluding hospitalizations with extreme costs (>100,000 CHF, N=39) or 154 
related to intensive care (N=85) as the latter are associated with high costs for specific 155 
categories (i.e. emergency, medical interventions). Statistical significance was considered for 156 
a two-sided test with p<0.05. 157 
Ethics statement 158 
The study was approved by the Ethics Commission of Canton Vaud (www.cer-vd.ch, 159 
decision 428-14, of Dec 2, 2014) and by the board of directors of the Lausanne university 160 
hospital (decision of Dec. 5, 2014). 161 
Results 162 
Patient characteristics  163 
Data from 8,538 hospitalizations for years 2013 and 2014 were collected. Of these 164 
5,999 (70.3%) were excluded because of missing data for NRS-2002, and a further 339 165 
(4.0%) because of missing data regarding socio-demographic or financial data, leaving 2,200 166 
(25.8%) hospitalizations for analysis. The characteristics of the included and excluded 167 
patients are summarized in Supplementary table 1. Excluded patients were younger, less 168 
frequently women, and had higher in-hospital mortality; excluded patients also had a shorter 169 
length of stay, a lower number of comorbidities, tended to be more frequently in the lowest 170 
category of the Charlson index, and had lower costs than included patients (Supplementary 171 
table 1). 172 
Characteristics of patients ‘not at-risk’ and ‘at-risk’  173 
The characteristics of patients nutritionally ‘not at-risk’ and ‘at-risk’ according to NRS-174 
2002 classification are summarized in Supplementary table 2. Patients ‘at-risk’ were older, 175 
more frequently women, came less frequently from home, had a longer length of stay, were in 176 
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the highest category of the Charlson index, had a higher number of comorbidities and a 177 
higher incidence of in-hospital mortality than patients ‘not at-risk’ (Supplementary table 2). 178 
Costs, reimbursements, and net results 179 
The total costs, reimbursements and net results according to presence or absence of 180 
nutritional risk are summarized in Tables 1 and 2. On bivariate analysis, hospitalizations ‘at-181 
risk’ had higher total costs, and a higher likelihood of being in the highest quartile or decile 182 
of costs. Hospitalizations ‘at-risk’ also led to higher reimbursements and had a higher 183 
likelihood of being in the highest quartile or decile of reimbursements. Finally, 184 
hospitalizations of nutritionally ‘at-risk’ patients led to higher differences between costs and 185 
reimbursements, were more frequently in the highest quartile or decile of differences between 186 
costs and reimbursements, and had a lower frequency of getting their costs completely 187 
covered (Table 1). 188 
These findings were further confirmed by multivariate analysis adjusting for sex, age 189 
(continuous), main diagnosis (9 categories), Charlson index category (5 groups), and in-190 
hospital mortality (Table 2). After multivariate adjustment, and compared to patients ‘not at-191 
risk’, patients ‘at-risk’ led an extra 3400 CHF (95% CI: 1200 to 5600 CHF) loss to the 192 
average difference between costs and reimbursements. Adjusting for number of comorbidities 193 
instead of the Charlson index led to similar findings (data not shown), patients ‘at-risk’ 194 
leading an extra 2500 CHF (95% CI: 370 to 4800 CHF) loss to the average difference 195 
between costs and reimbursements. Adjusting simultaneously for the number of 196 
comorbidities, Charlson index and GPC category led to similar conclusions (Supplementary 197 
table 3); further adjusting for total length of stay also led to similar conclusions 198 
(Supplementary table 4). 199 
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Similar conclusions were obtained in a sensitivity analysis excluding hospitalizations 200 
with total costs >100’000 CHF (N=39) or in intensive care (N=85) (Supplementary tables 5 201 
to 8), patients ‘at-risk’ leading an extra 1960 CHF (95% CI: 900 to 3000 CHF) loss to the 202 
average difference between costs and reimbursements. Finally, an inverse association 203 
between percentage of costs covered and length of stay was found in the overall sample 204 
(Spearman r=-0.146, p<0.001) and after excluding hospitalizations in intensive care or with 205 
total costs >100’000 CHF (Spearman r=-0.175, p<0.001). 206 
Specific costs 207 
The specific costs according to presence or absence of nutritional risk are summarized 208 
in Supplementary tables 9 and 10. On bivariate analysis, patients ‘at-risk’ had a higher 209 
percentage of costs related to units (housing) and a lesser percentage related to medical 210 
interventions, laboratory analyses and other (Supplementary table 9). Multivariate analysis 211 
showed that patients ‘at-risk’ had lower percentage of costs in medical interventions, food, 212 
imaging and other (p<0.05), but all absolute differences were less than 2% (Supplementary 213 
table 10). Sensitivity analysis excluding hospitalizations in intensive care or with total costs 214 
>100’000 CHF showed that patients ‘at-risk’ had lower percentage of costs in medical 215 
interventions, food, imaging and other (p <0.05) (Supplementary table 11). 216 
Discussion 217 
In this study we show that patients nutritionally ‘at-risk’ have higher costs but also 218 
higher reimbursements than patients ‘not at-risk’. Still, the higher reimbursement of patients 219 
nutritionally ‘at-risk’ fails to completely cover the excess costs among ‘at-risk’ patients. 220 
Thus, patients nutritionally ‘at-risk’ have a wider gap between costs and reimbursements (i.e. 221 
lead to greater losses for the hospital) than patients ‘not at-risk’. We also show that the 222 
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distribution of the main specific costs (expressed as percentage of total costs) does not vary 223 
considerably between ‘at-risk’ and ‘not at-risk’ patients. 224 
Availability of nutritional data in medical records 225 
Only one quarter (26%) of medical records had data for NRS-2002. This value is 226 
higher than reported in a Brazilian study (18.8%) [16] but lower than in a Canadian (33%) 227 
[17] or an Argentinean (38.8) studies [18]. Possible reasons are that the health care team fails 228 
to identify nutrition risk [19], the information is not collected [20] possibly due to time 229 
constraints [21], or it is collected but not inserted in the electronic file [22]. Given the 230 
considerable health and economic impact of undernutrition risk among hospitalized patients, 231 
inclusion of nutritional data in the electronic files should be made compulsory. 232 
Excluded patients had higher mortality but were younger and had lower number of 233 
comorbidities and a shorter length of stay than included ones. The younger age is due to 234 
lower screening rates among young patients [10], while the shorter length of stay could be 235 
due to the higher mortality and to the less complex disease. Our results suggest that health 236 
care teams select the patients based on their clinical status as indicated in the hospital 237 
guidelines, but avoid specific patients with end-of-life situations.” 238 
Costs, reimbursements, and net results 239 
Being nutritionally ‘at-risk’ was associated with higher total costs, a finding in 240 
agreement with the literature [4, 23]. For instance, in a previous review, we showed that, 241 
compared to well-nourished patients, patients at risk of undernutrition had higher 242 
hospitalization costs, ranging between 1640 and 5829€ per patient [5]. Similarly, an 243 
Australian study conducted among COPD patients showed that patients with an 244 
undernutrition code in their medical records had a total cost which was almost double than 245 
those who were well-nourished (AUD $23,652 vs. 12,362) [24]. This difference could partly 246 
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be due to an increased length of stay, although the higher costs among patients nutritionally 247 
‘at-risk’ persisted in the sensitivity analyses even after adjusting for total length of stay. 248 
Interestingly, the reimbursements obtained from nutritionally ‘at-risk’ patients were higher 249 
than the reimbursements of patients ‘not at-risk’; thus, one would expect that this increase in 250 
reimbursements would lead to a similar coverage of costs for both nutritionally ‘at-risk’ and 251 
‘not at-risk’ patients, but actually it was not the case, coverage rate being significantly lower 252 
among nutritionally ‘at-risk’ patients, a finding also reported by others [25, 26]. Possible 253 
explanations include the fact that coverage rates decrease with increasing length of stay or 254 
that undernutrition is frequently underreported in hospital discharge data [27, 28], thus 255 
leading to an inadequate DRG classification [25]. Therefore, it can be speculated that a better 256 
reporting of undernutrition might lead to increase reimbursement [29]. Still, presence of an 257 
undernutrition code in the discharge data does not forcibly lead to a different DRG code [26], 258 
and the impact of a better reporting of undernutrition on reimbursements remains to be 259 
evaluated. Finally, prompt screening and management of patients ‘at-risk’ of undernutrition 260 
might lead to cost savings of 1000 € per patient [30]. 261 
 An intervention aimed at better screening, management and reporting of 262 
undernutrition is currently ongoing at the department of internal medicine, and the results will 263 
be analyzed in 2017. 264 
Specific costs 265 
Few studies assessed the distribution of hospital costs for nutritionally ‘at-risk’ and 266 
‘not at-risk’ patients [31, 32]. In a community setting, Benković et al. estimated that, among 267 
patients with undernutrition, the share of total health costs for medications, hospitalizations, 268 
community nursing and (par)enteral nutrition was 42.6%, 33.7%, 13.1% and 6.7%, 269 
respectively, but no comparison with adequately nourished patients was performed [32]. In 270 
one hospital setting in Spain, patients with undernutrition had higher costs for hospital stay, 271 
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oral and artificial nutrition, and medicines [31]. These findings are partly in agreement with 272 
our results, where patients nutritionally ‘at-risk’ had a higher share of total costs associated 273 
with intensive care. Interestingly, expressing the costs as percentage of the total showed that 274 
Spanish patients with undernutrition also had a lower share of oral nutrition (1.1% vs. 1.7%), 275 
similar to our findings. Contrary to the Spanish study which evaluated artificial nutrition as 276 
representing almost 22% of total costs [31], it was not possible to quantify the specific cost of 277 
therapeutic or artificial nutrition in our study, as costs related to costs related to ONS, enteral 278 
and parenteral nutrition are not identifiable. Overall, our results suggest that the distribution 279 
of the different types of hospital costs between nutritionally ‘at-risk’ and ‘not at-risk’ patients 280 
varies, patients ‘at-risk’ having a higher share related to intensive care. Still, the absolute 281 
differences between ‘at-risk’ and ‘not at-risk’ patients were modest, never exceeding 2%. 282 
Hence, it can be inferred that being nutritionally ‘at-risk’ does not influence particularly one 283 
type of hospital costs; rather, it tends to increase all types of costs.  284 
Limitation of the study 285 
This paper has several limitations worth acknowledging. Firstly, only patients from 286 
the department of internal medicine of a university hospital were included, so our results 287 
might not be extrapolated to other departments or to peripheral hospitals. Also, the DRG 288 
system and level of reimbursement varies between countries [33], so the results obtained for 289 
Switzerland might not be applicable in other countries. Still, they provide a framework for the 290 
evaluation of the economic impact of undernutrition in hospitals, and it would be of interest 291 
to replicate this study in other settings or other countries. Secondly, it was not possible to 292 
obtain the value of the DRG point for 2013, so the value for 2014 was used instead. The 293 
higher value of DRG for year 2014 in comparison to year 2013, led to an overestimation of 294 
the amounts reimbursed and a probable underestimation of the difference between costs and 295 
reimbursements. Thirdly, the number of patients with NRS-2002 data was small, and they 296 
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differed significantly from the patients without information for nutritional risk. Hence, a 297 
possible selection bias cannot be ruled out, more severe patients benefiting from nutrition risk 298 
screening. Still, this selection bias would not influence the reimbursement of the costs, or the 299 
coverage of the latter. Fourthly, due to legal constraints, it was not possible to obtain the 300 
identification of the patients, which would have allowed their follow-up and thus other 301 
assessments such as the impact of risk of undernutrition on readmissions. Finally, it was not 302 
possible to characterize the “Other” types of cost, and costs related to medicines were 303 
underestimated as only “expensive” drugs (i.e. some types of chemotherapy, biological 304 
equivalents) were considered. 305 
Conclusion 306 
Patients nutritionally ‘at-risk’ have higher costs and higher reimbursements than 307 
patients ‘not at-risk’, but reimbursements fail to adequately cover the excess costs due to 308 
undernutrition, leading to higher financial losses for the hospitals. 309 
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Tables 406 
Table 1. Bivariate analysis of the costs, reimbursements and net balance for participants 407 
nutritionally ‘not at-risk’ and ‘at-risk’ according to the NRS-2002 criteria, department of 408 
internal medicine of the Lausanne university hospital, 2013-2014. 409 
 Not at-risk At-risk p-value 
N (%) 802 (36.5) 1398 (65.5)  
Total costs     
Amount (CHF) 16’171 
[11’142 – 24’748] 
19’982 
[13’684 – 33’785] 
<0.001 
>75th percentile (%) 140 (17.5) 410 (29.3) <0.001 
>90th percentile (%) 49 (6.1) 171 (12.2) <0.001 
Reimbursements    
Amount (CHF) 11’114 
[7802 – 18’186] 
13’346 
[8988 – 25’351] <0.001 
>75th percentile (%) 162 (20.2) 388 (27.8) <0.001 
>90th percentile (%) 49 (6.1) 157 (11.2) <0.001 
Difference (costs-reimbursements)    
Amount (CHF) 4239 
[187 - 8655] 
5651 
[1244 – 11’232] <0.001 
>75th percentile (%) 157 (19.6) 393 (28.1) <0.001 
>90th percentile (%) 54 (6.7) 166 (11.9) <0.001 
Coverage (%)    
Amount 72.2 [53.7 - 97.9] 69.9 [52.1 - 93] 0.084 
Complete 191 (23.8) 283 (20.2) 0.050 
19 
 
Results are expressed as number of patients (percentage) for categorical variables and as 410 
median [interquartile range] for continuous variables. Between-group comparisons performed 411 
using chi-square for categorical variables and Kruskal-Wallis test for continuous variables.  412 
20 
 
Table 2. Multivariate analysis of the costs, reimbursements and net balance for participants 413 
nutritionally ‘not at-risk’ and ‘at-risk’ according to the NRS-2002 criteria, department of 414 
internal medicine of the Lausanne university hospital, 2013-2014. 415 
 Not at-risk At-risk p-value 
N (%) 802 (36.5) 1398 (65.5)  
Total costs     
Amount (CHF) 22’214 ± 1666 34’206 ± 1246 <0.001 
>75th percentile (%) 1 (ref) 2.10 (1.66 - 2.66) <0.001 
>90th percentile (%) 1 (ref.) 2.36 (1.66 - 3.36) <0.001 
Reimbursements    
Amount (CHF) 17’783 ± 1477 26’376 ± 1105 <0.001 
>75th percentile (%) 1 (ref.) 1.53 (1.22 - 1.92) <0.001 
>90th percentile (%) 1 (ref.) 1.96 (1.37 - 2.79) <0.001 
Difference (costs-reimbursements)    
Amount (CHF) 4431 ± 881 7831 ± 660 0.003 
>75th percentile (%) 1 (ref.) 1.72 (1.37 - 2.15) <0.001 
>90th percentile (%) 1 (ref.) 2.09 (1.48 - 2.95) <0.001 
Coverage (%)    
Amount 82.6 ± 1.6 78.6 ± 1.2 0.044 
Complete 1 (ref.) 0.77 (0.62 - 0.97) 0.026 
Results are expressed as odds ratio (95% confidence interval) for categorical variables and as 416 
multivariate-adjusted mean ± standard error for continuous variables. Between-group 417 
comparisons performed using logistic regression for categorical variables and analysis of 418 
variance for continuous variables. Adjustment performed on sex, age (continuous), main 419 
diagnosis (9 categories), Charlson index category (5 groups), and in-hospital mortality. 420 
 421 
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Supplementary tables 
Supplementary table 1. Socio-demographic and clinical characteristics of excluded and 
included patients, department of internal medicine of the Lausanne university hospital, 2013-
2014. 
 Included Excluded p-value 
N (%) 2200 (25.8) 6338 (74.2)  
Age (years)     75.6 ± 15.5     71.9 ± 16.7 <0.001 
Women (%) 1186 (53.9) 3114 (49.1) <0.001 
Coming from home (%) 2053 (93.3) 5841 (92.2) 0.076 
In-hospital mortality (%) 120 (5.5) 439 (6.9) 0.016 
Length of stay (days) 14 [9 - 21] 11 [7 - 17] <0.001 § 
Charlson index (%)    
0 932 (42.4) 2914 (46.0) 0.003 
1 275 (12.5) 689 (10.9)  
2 343 (15.6) 1020 (16.1)  
3 146 (6.6) 324 (5.1)  
4+ 504 (22.9) 1391 (22.0)  
Number of comorbidities 5  [3 - 6] 4  [3 - 6] <0.001 § 
Total costs (CHF) 18’414 
[12’698 -  9’983] 
15’000 
[10’252 - 24’752] <0.001 § 
Results are expressed as number of patients (percentage) for categorical variables and as 
mean ± standard deviation or as median [interquartile range] for continuous variables. 
Between-group comparisons performed using chi-square for categorical variables and 
student’s t-test of Kruskal-Wallis (§) test for continuous variables. 
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Supplementary table 2: Socio-demographic and clinical characteristics of including patients 
according to nutritional status as assessed by NRS-2002, department of internal medicine of 
the Lausanne university hospital, 2013-2014. 
 Not at-risk At-risk p-value 
N (%) 778 (37.5) 1298 (62.5)  
Age (years)     71.4 ± 16.1    78.1 ± 14.6 <0.001 
Women (%) 381 (47.5) 805 (57.6) <0.001 
Coming from home (%) 765 (95.4) 1288 (92.1) 0.003 
In-hospital mortality (%) 16 (2.0) 104 (7.4) <0.001 
Length of stay (days) 12 [8 - 19] 15 [10 - 23] <0.001 § 
Charlson index (%)    
0 387 (48.3) 545 (39.0) <0.001 
1 92 (11.5) 183 (13.1)  
2 130 (16.2) 213 (15.2)  
3 45 (5.6) 101 (7.2)  
4+ 148 (18.5) 356 (25.5)  
Number of comorbidities         4 [3 - 6]         5 [3 - 7] <0.001 § 
Results are expressed as number of patients (percentage) for categorical variables and as 
mean ± standard deviation or as median [interquartile range] for continuous variables. 
Between-group comparisons performed using chi-square for categorical variables and 
student’s t-test or Kruskal-Wallis (§) test for continuous variables. 
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Supplementary table 3: Multivariate analysis of the costs, reimbursements and difference 
for hospitalizations nutritionally ‘not at-risk’ and ‘at-risk’, according to the NRS-2002 
criteria, department of internal medicine of the Lausanne university hospital, 2013-2014.  
 Not at-risk (n=802) At-risk (n=1398) p-value 
Total costs    
Amount (CHF) 26’152 ± 1378 31’947 ± 1029 0.001 
>75th percentile (%) 1 (ref.) 1.80 (1.38 - 2.35) <0.001 
>90th percentile (%) 1 (ref.) 1.80 (1.19 - 2.72) 0.005 
Reimbursements    
Amount (CHF) 21’110 ± 1259 24’467 ± 940 0.037 
>75th percentile (%) 1 (ref.) 1.23 (0.96 - 1.58) 0.104 
>90th percentile (%) 1 (ref.) 1.43 (0.96 - 2.13) 0.080 
Difference (cost-reimbursements)    
Amount (CHF) 5043 ± 872 7480 ± 651 0.029 
>75th percentile (%) 1 (ref.) 1.56 (1.24 - 1.96) <0.001 
>90th percentile (%) 1 (ref.) 1.71 (1.19 - 2.45) 0.004 
Coverage (%)    
Amount 82.8 ± 1.6 78.5 ± 1.2 0.032 
Complete 1 (ref.) 0.75 (0.60 - 0.94) 0.013 
Results are expressed as odds ratio (95% confidence interval) for categorical variables and as 
multivariate-adjusted mean ± standard error for continuous variables. Between-group 
comparisons performed using logistic regression for categorical variables and analysis of 
variance for continuous variables. Adjustment performed on sex, age (continuous), main 
diagnosis (9 categories), Charlson index category (5 groups), number of comorbidities 
(continuous), medical provision category (16 groups) and in-hospital mortality. 
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Supplementary table 4. Multivariate analysis of the costs, reimbursements and net balance 
for participants nutritionally ‘not at-risk’ and ‘at-risk’ according to the NRS-2002 criteria, 
department of internal medicine of the Lausanne university hospital, 2013-2014. 
 Not at-risk At-risk p-value 
N (%) 802 (36.5) 1398 (65.5)  
Total costs     
Amount (CHF) 29’277 ± 905 30’155 ± 675 0.449 
>75th percentile (%) 1 (ref.) 1.62 (1.08 - 2.44) 0.019 
>90th percentile (%) 1 (ref.) 1.18 (0.66 - 2.12) 0.576 
Reimbursements    
Amount (CHF) 24’110 ± 768 22’746 ± 573 0.165 
>75th percentile (%) 1 (ref.) 0.86 (0.63 - 1.17) 0.337 
>90th percentile (%) 1 (ref.) 0.92 (0.52 - 1.61) 0.758 
Difference (costs-reimbursements)    
Amount (CHF) 5167 ± 873 7409 ± 651 0.045 
>75th percentile (%) 1 (ref.) 1.45 (1.15 - 1.84) 0.002 
>90th percentile (%) 1 (ref.) 1.61 (1.11 - 2.32) 0.012 
Coverage (%)    
Amount 82.8 ± 1.6 78.6 ± 1.2 0.035 
Complete 1 (ref.) 0.74 (0.59 - 0.94) 0.011 
Results are expressed as odds ratio (95% confidence interval) for categorical variables and as 
multivariate-adjusted mean ± standard error for continuous variables. Between-group 
comparisons performed using logistic regression for categorical variables and analysis of 
variance for continuous variables. Adjustment performed on sex, age (continuous), main 
diagnosis (9 categories), Charlson index category (5 groups), number of comorbidities 
(continuous), medical provision category (16 groups), in-hospital mortality and total length of 
stay. 
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Supplementary table 5: Bivariate analysis of costs, reimbursements and net balance for 
hospitalizations nutritionally ’not at- risk’ and ‘at-risk’, according to the NRS-2002 criteria, 
department of internal medicine of the Lausanne university hospital, 2013-2014. 
Hospitalizations in intensive care (n=85) or with costs over 100’000 CHF (n=39) excluded. 
 Not at-risk (n=778) At-risk (n=1298) p-value 
Total costs ⱡ    
Amount (CHF) 15’822 
[11’046 - 23’953] 
19’066 
[13’302 - 29’605] 
<0.001 
>75th percentile (%) 147 (18.9) 372 (28.7) <0.001 
>90th percentile (%) 56 (7.2) 151 (11.6) 0.001 
Reimbursements    
Amount (CHF) 10’679 
[7739 - 16’958] 
12’276 
[8988 - 20’024] 
<0.001 
>75th percentile (%) 166 (21.3) 353 (27.2) 0.003 
>90th percentile (%) 54 (6.9) 152 (11.7) <0.001 
Difference (costs-reimbursements)    
Amount (CHF) 4221 
[223 - 8455] 
5480 
[1411 - 10’524] 
<0.001 
>75th percentile (%) 160 (20.6) 359 (27.7) <0.001 
>90th percentile (%) 55 (7.1) 152 (11.7) 0.001 
Coverage (%)    
Amount 72 [53.8 - 97.9] 69.5 [51.8 - 91.6] 0.042 
Complete 184 (23.7) 254 (19.6) 0.027 
Results are expressed as number of patients (percentage) for categorical variables and as 
median [interquartile range] for continuous variables. Between-group comparisons performed 
using chi-square for categorical variables and Kruskal-Wallis test for continuous variables. 
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Supplementary table 6: Multivariate analysis of the costs, reimbursements and difference 
for hospitalizations nutritionally ‘not at-risk’ and ‘at-risk’, according to the NRS-2002 
criteria, department of internal medicine of the Lausanne university hospital, 2013-2014. 
Hospitalizations in intensive care (n=85) or with costs over 100’000 CHF (n=39) excluded. 
 Not at-risk (n=778) At-risk (n=1298) p-value 
Total costs ⱡ    
Amount (CHF) 20’319 ± 578 24’691 ± 442 <0.001 
>75th percentile (%) 1 (ref.) 1.74 (1.38 - 2.21) <0.001 
>90th percentile (%) 1 (ref.) 1.70 (1.20 - 2.40) 0.003 
Reimbursements    
Amount (CHF) 16’303 ± 595 18’712 ± 455 0.002 
>75th percentile (%) 1 (ref.) 1.34 (1.06 - 1.68) 0.013 
>90th percentile (%) 1 (ref.) 1.73 (1.22 - 2.45) <0.001 
Difference (cost-reimbursements)    
Amount (CHF) 4016 ± 420 5980 ± 321 <0.001 
>75th percentile (%) 1 (ref.) 1.57 (1.25 - 1.97) <0.001 
>90th percentile (%) 1 (ref.) 2.00 (1.41 - 2.82) <0.001 
Coverage (%)    
Amount 82.3 ± 1.6 78.2 ± 1.2 0.041 
Complete 1 (ref.) 0.76 (0.60 - 0.96) 0.020 
Results are expressed as odds ratio (95% confidence interval) for categorical variables and as 
multivariate-adjusted mean ± standard error for continuous variables. Between-group 
comparisons performed using logistic regression for categorical variables and analysis of 
variance for continuous variables. Adjustment performed on sex, age (continuous), main 
diagnosis (9 categories), Charlson index category (5 groups), and in-hospital mortality. 
  
7 
 
Supplementary table 7: Multivariate analysis of the costs, reimbursements and difference 
for hospitalizations nutritionally ‘not at-risk’ and ‘at-risk’, according to the NRS-2002 
criteria, department of internal medicine of the Lausanne university hospital, 2013-2014. 
Hospitalizations in intensive care (n=85) or with costs over 100’000 CHF (n=39) excluded. 
 Not at-risk (n=778) At-risk (n=1298) p-value 
Total costs    
Amount (CHF) 20’923 ± 522 24’329 ± 399 <0.001 
>75th percentile (%) 1 (ref.) 1.66 (1.28 - 2.14) <0.001 
>90th percentile (%) 1 (ref.) 1.47 (1.02 - 2.14) 0.040 
Reimbursements    
Amount (CHF) 16’807 ± 557 18’410 ± 426 0.026 
>75th percentile (%) 1 (ref.) 1.23 (0.97 - 1.57) 0.090 
>90th percentile (%) 1 (ref.) 1.56 (1.08 - 2.26) 0.017 
Difference (cost-reimbursements)    
Amount (CHF) 4116 ± 419 5920 ± 320 <0.001 
>75th percentile (%) 1 (ref.) 1.49 (1.18 - 1.88) <0.001 
>90th percentile (%) 1 (ref.) 1.79 (1.25 - 2.55) <0.001 
Coverage (%)    
Amount 82.4 ± 1.6 78.1 ± 1.2 0.037 
Complete 1 (ref.) 0.75 (0.60 - 0.95) 0.017 
Results are expressed as odds ratio (95% confidence interval) for categorical variables and as 
multivariate-adjusted mean ± standard error for continuous variables. Between-group 
comparisons performed using logistic regression for categorical variables and analysis of 
variance for continuous variables. Adjustment performed on sex, age (continuous), main 
diagnosis (9 categories), Charlson index category (5 groups), number of comorbidities 
(continuous), medical provision category (16 groups) and in-hospital mortality. 
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Supplementary table 8: Multivariate analysis of the costs, reimbursements and difference 
for hospitalizations nutritionally ‘not at-risk’ and ‘at-risk’, according to the NRS-2002 
criteria, department of internal medicine of the Lausanne university hospital, 2013-2014. 
Hospitalizations in intensive care (n=85) or with costs over 100’000 CHF (n=39) excluded. 
 Not at-risk (n=778) At-risk (n=1298) p-value 
Total costs    
Amount (CHF) 22’382 ± 281 23’455 ± 214 0.003 
>75th percentile (%) 1 (ref.) 1.51 (1.02 - 2.24) 0.038 
>90th percentile (%) 1 (ref.) 0.99 (0.58 - 1.71) 0.982 
Reimbursements    
Amount (CHF) 18’048 ± 414 17’666 ± 316 0.474 
>75th percentile (%) 1 (ref.) 0.96 (0.71 - 1.30) 0.784 
>90th percentile (%) 1 (ref.) 1.18 (0.76 - 1.84) 0.453 
Difference (cost-reimbursements)    
Amount (CHF) 4334 ± 415 5789 ± 317 0.007 
>75th percentile (%) 1 (ref.) 1.34 (1.05 - 1.70) 0.019 
>90th percentile (%) 1 (ref.) 1.55 (1.07 - 2.25) 0.022 
Coverage (%)    
Amount 82.2 ± 1.6 78.3 ± 1.2 0.058 
Complete 1 (ref.) 0.76 (0.60 - 0.96) 0.021 
Results are expressed as odds ratio (95% confidence interval) for categorical variables and as 
multivariate-adjusted mean ± standard error for continuous variables. Between-group 
comparisons performed using logistic regression for categorical variables and analysis of 
variance for continuous variables. Adjustment performed on sex, age (continuous), main 
diagnosis (9 categories), Charlson index category (5 groups), number of comorbidities 
(continuous), medical provision category (16 groups), in-hospital mortality and total length of 
stay. 
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Supplementary table 9: Bivariate analysis of specific costs for hospitalizations nutritionally 
‘not at-risk’ and ‘at-risk’ according to the NRS-2002 criteria, department of internal medicine 
of the Lausanne university hospital, 2013-2014. 
 Not at-risk (n=802) At-risk (n=1398) p-value 
Units (housing) 34.8 [26.0 - 43.5] 38.4 [28.8 - 46.3] <0.001 
Medical interventions 16.6 [13.3 - 20.1] 15.1 [12.3 - 18.2] <0.001 
Food § 6.0 [5.0 - 6.9] 5.9 [4.9 - 6.8] 0.201 
Imaging 2.4 [0.9 - 5.8] 2.4 [0.9 - 4.7] 0.174 
Laboratory analyses 4.5 [3.0 - 6.6] 4.3 [2.9 - 6.1] 0.027 
Intensive care unit 5.4 [3.0 - 11.3] 4.8 [2.7 - 11.7] 0.252 
Other 14.8 [11.0 - 18.6] 13.0 [9.6 - 16.5] <0.001 
§ Excluding nutritional therapy. Only positions representing a median >1% of total costs are 
indicated. Results are expressed as % of total costs and as median [interquartile range]. 
Between-group comparisons performed using Kruskal-Wallis test. 
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Supplementary table 10: Multivariate analysis of specific costs for hospitalizations 
nutritionally ‘not at-risk’ and ‘at-risk’, according to the NRS-2002 criteria, department of 
internal medicine of the Lausanne university hospital, 2013-2014. 
 Not at-risk (n=802) At-risk (n=1398) p-value 
Units (housing) 35.6 ± 0.4 36.0 ± 0.3 0.461 
Medical intervention 16.8 ± 0.2 15.9 ± 0.1 <0.001 
Food § 6.0 ± 0.1 5.7 ± 0.1 <0.001 
Imaging 4.1 ± 0.2 3.7 ± 0.1 0.023 
Laboratory analyses 5.1 ± 0.1 5.1 ± 0.1 0.991 
Intensive care unit 8.9 ± 0.4 10.3 ± 0.3 0.005 
Other 15.0 ± 0.2 13.3 ± 0.1 <0.001 
§ Excluding nutritional therapy. Only positions representing a median >1% of total 
expenditures are indicated. Results are expressed as % of total costs and as multivariate-
adjusted mean ± standard error. Between-group comparisons performed using analysis of 
variance adjusting on sex, age (continuous), main diagnosis (9 categories), Charlson index 
category (5 groups), and in-hospital mortality. 
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Supplementary table 11: Multivariate analysis of specific costs for hospitalizations 
nutritionally ‘not at-risk’ and ‘at-risk’, according to the NRS-2002 criteria, department of 
internal medicine of the Lausanne university hospital, 2013-2014. Hospitalizations in 
intensive care or with expenditures over 100’000 CHF excluded. 
 Not at risk (n=778) At risk (n=1298) p-value 
Units (housing) 36.1 ± 0.4 37.1 ± 0.3 0.073 
Medical intervention 16.9 ± 0.2 16.1 ± 0.1 0.003 
Food § 6.1 ± 0.1 5.9 ± 0.1 0.004 
Imaging 4.0 ± 0.1 3.6 ± 0.1 0.036 
Laboratory analyses 5.0 ± 0.1 5.1 ± 0.1 0.564 
Intensive care unit 8.6 ± 0.4 8.9 ± 0.3 0.490 
Other 15.2 ± 0.2 13.8 ± 0.1 <0.001 
ⱡ Hospitalizations in intensive care (n=85) or with costs over 100’000 CHF (n=39) were 
excluded. § excluding nutritional therapy. Only positions representing a median >1% of total 
expenditures are indicated. Results are expressed as % of total costs and as multivariate-
adjusted mean ± standard error. Between-group comparisons performed using analysis of 
variance adjusting on sex, age (continuous), main diagnosis (9 categories), Charlson index 
category (5 groups), and in-hospital mortality. 
 
